€39M Series B to Fund Biopolymers for Surgery and Implants

The French company Tissium has raised a €38.8M Series B round to fund the development of polymers that can be used to repair blood vessels and nerves. ontributing to the round were newcomers to Tissium such as the European Investment Fund and returning investors such as the investment bank Bpifrance and French life sciences VC firm Sofinnova Partners. Tissium, formerly known as Gecko Biomedical, develops polymers that can act as surgical glue or be 3D-printed as implants. The company has an EU-approved polymer glue that is used to seal blood vessels in surgery. Called Setalum, the glue sets when hit with a beam of light, making it easy for surgeons to apply and control it during complicated surgeries. In one clinical study, the glue halted bleeding in 85% of the enrolled patients.